BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 2325662)

  • 21. Heterogeneity in the gene locus for steroid 21-hydroxylase deficiency.
    Rumsby G; Fielder AH; Hague WM; Honour JW
    J Med Genet; 1988 Sep; 25(9):596-9. PubMed ID: 3263505
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered CYP21 genes in HLA-haplotypes associated with congenital adrenal hyperplasia (CAH): a family study.
    Manfras BJ; Swinyard M; Rudert WA; Ball EJ; Lee PA; Kühnl P; Trucco M; Böhm BO
    Hum Genet; 1993 Aug; 92(1):33-9. PubMed ID: 8365724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linkage between I172N mutation, a marker of 21-hydroxylase deficiency, and a single nucleotide polymorphism in Int6 of CYP21B gene: a genetic study of Sardinian family.
    Concolino P; Satta MA; Santonocito C; Carrozza C; Rocchetti S; Ameglio F; Giardina E; Zuppi C; Capoluongo E
    Clin Chim Acta; 2006 Feb; 364(1-2):298-302. PubMed ID: 16171792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A de novo pathological point mutation at the 21-hydroxylase locus: implications for gene conversion in the human genome.
    Collier S; Tassabehji M; Sinnott P; Strachan T
    Nat Genet; 1993 Mar; 3(3):260-5. PubMed ID: 8485582
    [TBL] [Abstract][Full Text] [Related]  

  • 25. R339H and P453S: CYP21 mutations associated with nonclassic steroid 21-hydroxylase deficiency that are not apparent gene conversions.
    Helmberg A; Tusie-Luna MT; Tabarelli M; Kofler R; White PC
    Mol Endocrinol; 1992 Aug; 6(8):1318-22. PubMed ID: 1406709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High variability of CYP21 gene rearrangements in Spanish patients with classic form of congenital adrenal hyperplasia.
    Lobato MN; Aledo R; Meseguer A
    Hum Hered; 1998; 48(4):216-25. PubMed ID: 9694253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A method for specific amplification and PCR sequencing of individual members of multigene families: application to the study of steroid 21-hydroxylase deficiency.
    Collier S; Tassabehji M; Strachan T
    PCR Methods Appl; 1992 Feb; 1(3):181-6. PubMed ID: 1472941
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allele-dropout using PCR-based diagnosis for the splicing mutation in intron-2 of the CYP21B-gene: successful amplification with a Taq/Pwo-polymerase mixture.
    Schulze E; Bettendorf M; Maser-Gluth C; Decker M; Schwabe U
    Endocr Res; 1998; 24(3-4):637-41. PubMed ID: 9888552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutations in steroid 21-hydroxylase (CYP21).
    White PC; Tusie-Luna MT; New MI; Speiser PW
    Hum Mutat; 1994; 3(4):373-8. PubMed ID: 8081391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene conversion in steroid 21-hydroxylase genes.
    Urabe K; Kimura A; Harada F; Iwanaga T; Sasazuki T
    Am J Hum Genet; 1990 Jun; 46(6):1178-86. PubMed ID: 1971153
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular genetics of congenital adrenal hyperplasia.
    White PC; New MI
    Baillieres Clin Endocrinol Metab; 1988 Nov; 2(4):941-65. PubMed ID: 3077248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and genetic characterization of nonclassic 21-hydroxylase deficiency.
    Speiser PW; New MI; White PC
    Endocr Res; 1989; 15(1-2):257-76. PubMed ID: 2788081
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular pathology of 21-hydroxylase deficiency.
    Strachan T
    J Inherit Metab Dis; 1994; 17(4):430-41. PubMed ID: 7967493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Major-histocompatibility-complex gene markers and restriction-fragment analysis of steroid 21-hydroxylase (CYP21) and complement C4 genes in classical congenital adrenal hyperplasia patients in a single population.
    Partanen J; Koskimies S; Sipilä I; Lipsanen V
    Am J Hum Genet; 1989 May; 44(5):660-70. PubMed ID: 2565078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low frequency of CYP2B deletions in Brazilian patients with congenital adrenal hyperplasia due to 21-hydroxylas deficiency.
    Bachega TA; Billerbeck AE; Madureira G; Arnhold IJ; Medeiros MA; Marcondes JA; Longui CA; Nicolau W; Bloise W; Mendonca BB
    Hum Hered; 1999 Jan; 49(1):9-14. PubMed ID: 10189236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Salt-wasting congenital adrenal hyperplasia: detection of mutations in CYP21B gene in a Chilean population.
    Fardella CE; Poggi H; Pineda P; Soto J; Torrealba I; Cattani A; Oestreicher E; Foradori A
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3357-60. PubMed ID: 9745454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulsed field gel electrophoresis identifies a high degree of variability in the number of tandem 21-hydroxylase and complement C4 gene repeats in 21-hydroxylase deficiency haplotypes.
    Collier S; Sinnott PJ; Dyer PA; Price DA; Harris R; Strachan T
    EMBO J; 1989 May; 8(5):1393-402. PubMed ID: 2788573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of steroid 21-hydroxylase alleles using gene-specific PCR and a multiplexed ligation detection reaction.
    Day DJ; Speiser PW; White PC; Barany F
    Genomics; 1995 Sep; 29(1):152-62. PubMed ID: 8530065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical phenotype and mutation spectrum of the CYP21A2 gene in patients with steroid 21-hydroxylase deficiency.
    Choi JH; Jin HY; Lee BH; Ko JM; Lee JJ; Kim GH; Jung CW; Lee J; Yoo HW
    Exp Clin Endocrinol Diabetes; 2012 Jan; 120(1):23-7. PubMed ID: 22020670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutational spectrum of the steroid 21-hydroxylase gene in Austria: identification of a novel missense mutation.
    Baumgartner-Parzer SM; Schulze E; Waldhäusl W; Pauschenwein S; Rondot S; Nowotny P; Meyer K; Frisch H; Waldhauser F; Vierhapper H
    J Clin Endocrinol Metab; 2001 Oct; 86(10):4771-5. PubMed ID: 11600539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.